Clinical Trial Update: Ability of Pupillometry to Reduce Sufentanil Consumption in Planned Cardiac Surgery: Randomized, Controlled, Single-center Clinical Superiority Trial [NA]

View source ↗

Summary

This document reports a completed randomized, single-center trial evaluating pupillometry to reduce sufentanil consumption during planned cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Sufentanil (sufentanil)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Patients Undergoing Cardiac Surgery, Patients With Coronary Artery Bypass Surgery With CEC | NA | Status: COMPLETED